NEW YORK--(BUSINESS WIRE)--Anju Software Inc., a life sciences software platform backed by Providence Equity Partners, today announced that it has acquired San Francisco-based Zephyr Health, a company that provides comprehensive physician, institution and treatment data for every major disease area. Zephyr uses proprietary algorithms to link disparate data sources delivering actionable insights.
With this acquisition, Anju continues to execute on combining robust software with actionable data to create tremendous value to its customers, which include pharmaceutical companies, clinical research organizations (CRO), [full service] agencies and medical device companies. The acquisition of Zephyr also expands Anju's geographical footprint to San Francisco, London, U.K. and Pune, India.
“Zephyr Health, MDC and Open Q, when combined. offer the most comprehensive data solution currently available to provide focused data for site and investigator optimization for clinical trials, provide key opinion leader (KOL) optimization for medical affairs and for commercializing a drug,” said Mr. Kurien Jacob, CEO of Anju Software.
“We are pleased to combine Zephyr with Anju and have been encouraged by Anju's vision for creating the next generation platform for the life sciences industry,” added Brook Byers, an early investor in Zephyr and co-founder of Kleiner Perkins Caufield & Byers.
“Zephyr’s big data analytics solution enables Anju’s pharmaceutical customers to improve research efficacy and significantly reduce the time it takes to bring life-saving therapies to market,” said Gopi Vaddi, Providence Strategic Growth Managing Director and a member of the Anju Board. “Zephyr is an ideal fit with Kurien’s vision for Anju as the Company continues to execute on its strong growth strategy.”
“Providence is excited about the platform that is being built by the Anju team,” said Alexis Egan, a Providence Strategic Growth Senior Advisor.
Mr. Byers and Joe Horowitz, managing general partner of Icon Ventures and an investor in Zephyr, will serve in an advisory capacity to Anju.
About Anju Software
Anju Software (“Anju”) is a leading provider of comprehensive software and data solutions to the life sciences industry. Anju provides an integrated platform spanning clinical, medical affairs and commercial operations. Anju has combined deep industry and software domain expertise to build a next generation platform for the life sciences sector that can scale to provide solutions that meet customers' needs from “molecule to retirement”. Anju solutions are used by large and small pharmaceutical companies, clinical research organizations, full service agencies and medical device companies. Data flow between functional areas, seamless communication with third party systems and AI-based data mining solutions provide a unique way for Anju customers to leverage critical information throughout their ecosystem. For more information, please visit www.anjusoftware.com
About Zephyr Health
Founded in 2011, Zephyr Health is the leading insights-as-a-service company harnessing the power of global healthcare data for precise and confident product lifecycle performance for biopharmaceutical and medical device companies, focused on commercial and medical affairs areas of Pharma and Medical Devises Zephyr Health is venture backed by Kleiner Perkins Caufield & Byers, Icon Ventures, and Google Ventures. For more information, please visit: www.zephyrhealth.com.
About Providence Equity
Providence Equity Partners (“Providence”) is a premier, global asset management firm with approximately $60 billion in assets under management across complementary private equity and credit businesses. Providence pioneered a sector-focused approach to private equity, investing with the vision that a dedicated team of industry experts could build exceptional companies of enduring value. Since the firm’s inception in 1989, Providence has invested in more than 180 companies and has become a leading equity investment firm focused on the media, communications, education and information industries. Providence is headquartered in Providence, RI, and also has offices in New York and London. For more information, please visit www.proveequity.com